As many as 62% of attendees at the Academy of Integrative Health & Medicine annual conference this week said that the most important factor in stopping Ebola in the United States is controlling the virus and caring for afflicted patients in West Africa.
Dollar General announced that it has extended its tender offer to acquire all outstanding shares of Family Dollar Stores to 5:00 p.m., New York City time, on Dec. 31, 2014.
Diabetes treatment with a low-cost generic drug can have significant, positive implications for a patient's quality of life and medication cost, according to new research from CVS Health.
The board of directors of Fred's Super Dollar on Thursday named Jerry Shore CEO of the company.
Sandoz, through its branded dermatology business PharmaDerm, and Medigene AG on Thursday announced a promotion agreement with Women's Choice Pharmaceuticals for Veregen (sinecatechins) ointment, 15% strength.
Global consumer confidence edged up one index point in the third quarter to a score of 98 — an increase of one point from the previous quarter and two points from the start of the year.
Wakefern Food Corp. reached a record sales level of $14.7 billion in retail sales for the fiscal year ended Sept. 27, a 4% increase from the same period last year, and $11.9 billion in Wakefern sales, the company reported during its annual shareholder meeting on Thursday.
AmerisourceBergen on Thursday reported that in its fiscal year 2014 fourth quarter ended Sept. 30 revenue increased 29.1% to $31.6 billion in the quarter.
AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes.
Cardinal Health reported fiscal year 2015 first-quarter revenue of $24.1 billion, representing a 2% decline from the year-ago period.